Skip to main content

Table 14 Heart Rate Variability

From: A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's disease

 

Ketogenic Diet

Standard Diet

Day 1

Day 7

Week 3

Day 1

Day 7

Week 3

VM1 max

92.08 (3.95)

99.78 (7.05)

95.3 (9.37)

88.13 (7.79)

92.11 (9.59)

91.62 (16.9)

VM1 min

68.44 (7.19)

67.89 (7.47)

68.9 (6.42)

65.96 (5.11)

69.79 (5.64)

69.05 (7.99)

VR1

1.36 (0.14)

1.48 (0.19)

1.39 (0.17)

1.34 (0.15)

1.33 (0.1)

1.33 (0.17)

VM2 max

93.87 (3.87)

98.93 (4.93)

100.59 (22.12)

89.11 (7.47)

91.42 (12.13)

86.98 (11.21)

VM2 min

70.99 (6.18)

68.38 (6.64)

70.09 (8.4)

66.2 (7.18)

71.4 (7.23)

67.45 (8.84)

VR2

1.33 (0.11)

1.45 (0.12)

1.44 (0.26)

1.35 (0.09)

1.28 (0.11)

1.29 (0.12)

VR Avg

1.34 (0.1)

1.47 (0.16)

1.41 (0.2)

1.35 (0.11)

1.3 (0.1)

1.29 (0.12)

Inspiratory HR

73.94 (7.94)

80.14 (4.96)

75.87 (3.12)

73.29 (6.82)

78.66 (9.32)

74.82 (8.19)

Expiratory HR

68.78 (8.22)

72.96 (6.16)

70.2 (6.01)

67.54 (5.8)

71.16 (7.49)

69.2 (7.69)

E/I

1.08 (0.06)

1.1 (0.06)

1.09 (0.07)

1.09 (0.05)

1.11 (0.06)

1.08 (0.05)

  1. VM Valsalva Maneuver (bpm), VR Valsalva Ratio, E/I Expiratory:Inspiratory ratio.
  2. Blood pressure orthostatic testing showed no clear effect from the intervention in either group (Table 15).